Skip to main content
Top
Published in: Clinical Rheumatology 4/2006

01-07-2006 | Original Article

Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis

Authors: Predrag Ostojić, Nemanja Damjanov

Published in: Clinical Rheumatology | Issue 4/2006

Login to get access

Abstract

This study aims to analyze differences among established disease damage indicators in patients with limited cutaneous systemic sclerosis (lcSSc) and diffuse cutaneous systemic sclerosis (dcSSc). Fifty patients with lcSSc and 55 patients with dcSSc were included in this study. Difference in mean disease duration between the two subgroups of patients was not statistically significant (z=−0.88, p=0.38). Patients with lcSSc and dcSSc were compared, and differences in vascular, esophageal, lung, heart, renal, and musculoskeletal involvement were statistically assessed using χ 2, Mann–Whitney, and Kruskal–Wallis tests. Using the technique of nailfold capillaroscopy, we found normal capillaries or nonspecific capillary change in 10.0% of the patients with lcSSc and only in 3.6% of the patients with dcSSc. Dilated capillaries without loss of capillaries were found in 42% of the patients with lcSSc and in 10.9% of the patients with dcSSc (p=0.05). However, severe capillary damage (loss of capillaries) was noticed more frequently in patients with dcSSc (dcSSc/lcSSc: 85.5%/48.0%, p=0.002). Pitting scars or digital ulcers were found in 46.0% of the patients with lcSSc and in 67.3% of the patients with dcSSc (p=0.04). We did not notice a significant difference in frequency of fingertip osteolysis and telangiectasia. Esophageal hypomotility was found in 64% of the patients with lcSSc and in 85.5% of the patients with dcSSc (p<0.01). We found interstitial lung fibrosis more frequently in patients with dcSSc (lcSSc/dcSSc: 16.0%/72.7%, p<0.001). Reduced forced vital capacity (FVC) was found in 6.0% of the of patients with lcSSc and in 41.8% of the patients with dcSSc (p<0.001). A decreased value of the transfer factor for carbon monoxide (DLCO) was also observed more frequently in patients with dcSSc. Heart involvement was found in 29.1% of the patients with dcSSc and less frequently (p<0.001) in patients with lcSSc (8%). Similarly, we found renal involvement more frequently in patients with dcSSc (lcSSc/dcSSc: 2.0%/16.3%). Tendon friction rubs were noticed in 23.6% of the patients with dcSSc and only in 6% of the patients with lcSSc (p<0.01). Joint contractures were observed in 70.9% of the patients with dcSSc and in 26.0% of the patients with lcSSc (p<0.001). Muscle weakness was noticed more frequently in patients with dcSSc (lcSSc/dcSSc: 22.0%/40.0%, p<0.05). Arthralgia was found more frequently in patients with dcSSc, but arthritis became apparent, without significant difference in frequency, in 16% of the patients with lcSSc and in 16.4% of the patients with dcSSc. Loss of capillaries (detected by nailfold capillaroscopy), digital ulcers, interstitial lung fibrosis, decreased FVC and DLCO, esophageal hypomotility, musculoskeletal impairment, and heart and renal involvement are more common in patients with dcSSc. Fingertip osteolysis, telangiectasia, and arthritis are equally frequent in both forms of the disease.
Literature
1.
go back to reference Seibold JR (1997) Scleroderma. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 5th edn. Saunders, Philadelphia, pp 1133–1163 Seibold JR (1997) Scleroderma. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 5th edn. Saunders, Philadelphia, pp 1133–1163
2.
go back to reference Cervini C, Grassi W (1996) Raynaud's phenomenon. Rheumatol Eur 25(3):111–113 Cervini C, Grassi W (1996) Raynaud's phenomenon. Rheumatol Eur 25(3):111–113
3.
go back to reference Kahleh MB, Suttany GL, Smith EA et al (1986) A modified scleroderma skin scoring method. Clin Exp Rheumatol 14:367–369 Kahleh MB, Suttany GL, Smith EA et al (1986) A modified scleroderma skin scoring method. Clin Exp Rheumatol 14:367–369
4.
go back to reference Behr J, Vogelmeier C, Beinert T et al (1996) Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Clin Exp Rheumatol 154:400–406 Behr J, Vogelmeier C, Beinert T et al (1996) Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Clin Exp Rheumatol 154:400–406
5.
go back to reference Preston IR, Hill NS (2003) Evaluation and management of pulmonary hypertension in systemic sclerosis. Curr Opin Rheumatol 15(6):761–765PubMedCrossRef Preston IR, Hill NS (2003) Evaluation and management of pulmonary hypertension in systemic sclerosis. Curr Opin Rheumatol 15(6):761–765PubMedCrossRef
6.
go back to reference Seibold JR (1993) Scleroderma. In: Kelley WN (ed) Arthritis and allied conditions. Saunders, Philadelphia, pp 1113–1143 Seibold JR (1993) Scleroderma. In: Kelley WN (ed) Arthritis and allied conditions. Saunders, Philadelphia, pp 1113–1143
7.
go back to reference Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590 Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590
8.
go back to reference Le Roy EC, Black C, Fleischmajer et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205 Le Roy EC, Black C, Fleischmajer et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
9.
go back to reference Giordano M, Valentini G, Migliaresi S et al (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13:202–205 Giordano M, Valentini G, Migliaresi S et al (1986) Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 13:202–205
10.
go back to reference Damjanov N (1995) Significance of capillaroscopic findings for the diagnosis of systemic sclerosis. Acta Rheumatol Belgrad 15(1):61–86 Damjanov N (1995) Significance of capillaroscopic findings for the diagnosis of systemic sclerosis. Acta Rheumatol Belgrad 15(1):61–86
11.
go back to reference Jacobsen S, Halberg P, Ullman S et al (1998) Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. J Rheumatol 37:39–45CrossRef Jacobsen S, Halberg P, Ullman S et al (1998) Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. J Rheumatol 37:39–45CrossRef
12.
go back to reference Steen VD, Powell DL, Medsger TA Jr (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31:196–203PubMedCrossRef Steen VD, Powell DL, Medsger TA Jr (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31:196–203PubMedCrossRef
13.
go back to reference Satoh M, Akizuki M, Kuwana M et al (1994) Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma. J Rheumatol 21:111–114PubMed Satoh M, Akizuki M, Kuwana M et al (1994) Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma. J Rheumatol 21:111–114PubMed
14.
go back to reference Harris M, Rosen A (2003) Autoimmunity on scleroderma: the origin, pathogenetic role, and clinical significance of autoantiodies. Curr Opin Rheumatol 15:778–784PubMedCrossRef Harris M, Rosen A (2003) Autoimmunity on scleroderma: the origin, pathogenetic role, and clinical significance of autoantiodies. Curr Opin Rheumatol 15:778–784PubMedCrossRef
15.
go back to reference Morelli S, Barbieri C, Sgreccia A et al (1997) Relationship between cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol 24:81–85PubMed Morelli S, Barbieri C, Sgreccia A et al (1997) Relationship between cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol 24:81–85PubMed
16.
go back to reference Kane GC, Varga J, Conant EF et al (1996) Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement and autoantibody status. Respir Med 90:223–230PubMedCrossRef Kane GC, Varga J, Conant EF et al (1996) Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement and autoantibody status. Respir Med 90:223–230PubMedCrossRef
17.
go back to reference Diot E, Giraudeau B, Diot P et al (1999) Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis? Chest 116:715–720PubMedCrossRef Diot E, Giraudeau B, Diot P et al (1999) Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis? Chest 116:715–720PubMedCrossRef
18.
go back to reference Steen V, Medsger T (2000) Severe organ involvement in patient with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef Steen V, Medsger T (2000) Severe organ involvement in patient with diffuse scleroderma. Arthritis Rheum 43:2437–2444PubMedCrossRef
19.
go back to reference Denton C (2003) Renal complications of systemic sclerosis. Ann Rheum Dis 62(Suppl 1):SP0014 Denton C (2003) Renal complications of systemic sclerosis. Ann Rheum Dis 62(Suppl 1):SP0014
20.
go back to reference Della Rosa A, Valentini G, Bombardieri A et al (2001) European multicentre study to define disease activity criteria for systemic sclerosis. Clinical and epidemiological features of 290 patients from 19 centers. Ann Rheum Dis 60:585–591CrossRef Della Rosa A, Valentini G, Bombardieri A et al (2001) European multicentre study to define disease activity criteria for systemic sclerosis. Clinical and epidemiological features of 290 patients from 19 centers. Ann Rheum Dis 60:585–591CrossRef
Metadata
Title
Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis
Authors
Predrag Ostojić
Nemanja Damjanov
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0041-0

Other articles of this Issue 4/2006

Clinical Rheumatology 4/2006 Go to the issue